234
Participants
Start Date
December 30, 2019
Primary Completion Date
October 27, 2022
Study Completion Date
October 27, 2022
Tropifexor
100mcg+30mcg+10mcg capsules of tropifexor taken orally every day until the 140 mcg capsule of tropifexor taken orally every day is produced, then patients will switch to the single 140mcg capsule taken orally every day
Licogliflozin
30mg tablet of licoglifozin taken orally every day
Placebo
licogliflozin placebo + tropifexor placebo
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Mechelen
Novartis Investigative Site, Port Elizabeth
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Aarhus N
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Berlin
Northwell Health, Manhasset
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Milan
Novartis Investigative Site, México
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Diabetes And Endocrinology Conslt, Morehead City
Clinical Trials Of America LLC, Lenoir
Palmetto Clinical Research, Summerville
Prisma Health, Greenville
Digestive Disease Research, Greenwood
Integrity Clinical Rsh LLC, Doral
Galenus Group, Lehigh Acres
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Padua
Gut PC Digestive Health Specialist, Dothan
Summit Medical Care, Hermitage
Southern Therapy and Adv Res LLC, Jackson
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Essen
Digestive Res Alliance of Michiana, South Bend
Novartis Investigative Site, Mainz
Clinical Research Professionals Inc, Chesterfield
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Tainan City
Options Health Research, Tulsa
Dallas Diabetes and Endocrine Center, Dallas
Texas Clinical Research Institute, Arlington
Pioneer Research Solutions, Sugar Land
American Research Corporation at Texas Liver Institute, San Antonio
Clinical Trials of Texas, San Antonio
Endeavor Clinical Trials, San Antonio
Novartis Investigative Site, Kaohsiung City
Southwest Gastroenterology Associates, Albuquerque
Velocity Clinical Trials, Los Angeles
Novartis Investigative Site, Palermo
California Liver Research Institute, Pasadena
San fernando Valley Health Institute, Van Nuys
Southern California Research Center, Coronado
Medical Associates Research Group, San Diego
Island View Gastroenterology Associates, Ventura
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Samara
Novartis Investigative Site, Novosibirsk
Novartis Investigative Site, Viña del Mar
Novartis Investigative Site, Valdivia
Genoma Research Group Inc, Miami
Novartis Investigative Site, San Juan Bautista
Novartis Investigative Site, Salvador
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Montreal
Novartis Investigative Site, Medellín
Novartis Investigative Site, Rionegro
Novartis Investigative Site, Dresden
Novartis Investigative Site, Takamatsu
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Saga
Novartis Investigative Site, Izumo
Novartis Investigative Site, Cuauhtémoc
FDI Clinical Research, San Juan
Novartis Investigative Site, Dongjak Gu
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Aberdeen
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY